CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 13,158 shares (grant or award)
- 4 Other disposition President and CEO disposed of 56,332 shares (code )
- 4 Planned sale President and CEO sold 84,000 shares at an average $3.82 ($321,134)
- 4 Planned sale Chief Financial Officer sold 60,000 shares at an average $3.89 ($233,388)
- 4 Planned sale Chief Medical Officer sold 60,000 shares at an average $3.87 ($232,402)
- 4 Planned sale Chief Medical Officer sold 8,125 shares at $4.07 ($33,089)
- 4/A Open-market buy Director bought 5,500 shares at $3.55 ($19,514)
- 4/A Open-market buy Director bought 5,500 shares at $3.55 ($19,514)
- 4 Open-market buy Director bought 700 shares at $3.73 ($2,611)
- 4 Open-market buy Director bought 5,500 shares at $3.55 ($19,514)
- 4 Open-market buy Director bought 700 shares at $3.73 ($2,611)
- 4 Planned sale President and CEO sold 7,829 shares at $7.06 ($55,241)
- 4 Planned sale Chief Medical Officer sold 19,442 shares at $7.04 ($136,872)
- 4 Planned sale Director sold 24,499 shares at $7.04 ($172,424)
- 4 Open-market sale 10% owner sold 30,681 shares at $6.66 ($204,335)
- 4 Planned sale Director sold 28,210 shares at an average $6.28 ($177,208)
- 4 Planned sale Director sold 175,790 shares at an average $6.00 ($1,055,311)
- 4/A Open-market sale 10% owner sold 162,069 shares at an average $5.68 ($920,855)
- 4 Open-market sale 10% owner sold 150,000 shares at an average $5.68 ($851,700)
Page 2 of 39 · 776 filings